Skip to main content

Industry News

Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.

Wyeth Opens Biotech Production Facility in Ireland

Published 9/7/2005

Wyeth Pharmaceuticals opened its 1.2 million-sf Grange Castle biotech production facility on September 8, 2005. Located in South County Dublin, Ireland, the $2 billion project began site work in October of 2002. Employing over 1,000 workers, the facility is comprised of three separate buildings: a drug development unit, a drug substance site, and a drug product facility. Production will begin on a phased basis over the next four years.

Read More

University of Louisville To Build Regional Biosafety Laboratory

Published 9/7/2005

The National Institutes of Health's National Institute for Allergy and Infectious Diseases (NIAID) has awarded the University of Louisville a $22 million federal grant to construct a biodefense research laboratory on its Shelby campus. One of thirteen BSL-3 Regional Biosafety Laboratories in the nation funded by NIAID since 2003, the 45,000-sf facility will be supported by $12.6 million in University funding. The building will house the University's Center for Predictive Medicine.

Read More

George Mason University Constructs National Center for Biodefense and Infectious Diseases

Published 9/7/2005

The National Institutes of Health's National Institute of Allergy and Infectious Diseases has awarded George Mason University (GMU) a $25-million grant to construct a new BSL-3 biocontainment laboratory in Fairfax, Va. The facility will be part of GMU's $45-million National Center for Biodefense and Infectious Diseases, an 83,000-sf facility that will accommodate research on diseases considered to be potential bioterror threats.

Read More

University of Hawaii Constructs Biodefense Laboratory

Published 9/5/2005

The University of Hawaii has been awarded a $25 million grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases to construct a new biodefense laboratory in Pearl City. The BSL-3 facility will be sited near the existing state Department of Health laboratory and may receive additional funding from a proposed $12 million state grant. Construction of the new biocontainment laboratory is slated to begin in fall 2006.  

Read More